Catherine M. Engelbert Royalty Pharma PLC (RPRX) insider trading activity
Catherine M. Engelbert is Director of Royalty Pharma plc. Currently has a direct ownership of 43,514 shares of RPRX, which is worth approximately $1.18 Million. The most recent transaction as insider was on Jun 07, 2024, when has been sold 9,293 shares (Class A Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
43.5K
0%
3M change
31.02%
12M change
Total Value Held
$1.18 Million
Catherine M. Engelbert Transaction History
Also insider at
CME
Catherine M. Engelbert
Director
Chicago, IL